Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New dental implant shows promise in replacing missing teeth

NCT ID NCT05062863

Disease control Sponsor: ZimVie Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jul 29, 2026 · Updated 5 times

Summary

This study looked at how well the T3 dental implant system works for people with missing teeth. Researchers placed implants in the upper or lower jaw and checked them over two years. The main goal was to see if the implants stayed firmly in place, and they found good integration success.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
T3 dental implant system
What this could lead to
If successful, this implant could provide a reliable, long-lasting option for replacing missing teeth, improving chewing and appearance.
What could go wrong
This is an observational study with no comparison group, so results may not apply to everyone. Risks include implant failure, infection, or bone loss.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

139 people

The number who actually took part.

Started

Oct 2021

Finished

Jul 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Qualified patient will be those patients who have been newly diagnosed with needing a dental implant (or more than one) in one or more edentulous areas in the maxilla and/or mandible. Patients who have had prior implants in the treatment site that have failed (in need of revision) are not eligible for inclusion.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients of either sex and at least 18 years of age. 2. Patients for whom a decision has already been made to use a dental implant for the restoration of existing edentulism in the mandible and/or maxilla. 3. Prior extracted sites or simultaneous extraction/implant placement. 4. Patients must be physically able to tolerate conventional surgical and restorative procedures. 5. Patients who provide a signed informed consent. 6. Patients who agree to be evaluated for each study visit. Exclusion Criteria: 1. Patients who are known to be pregnant at the screening visit or planning to become pregnant within 6 months of study enrollment. 2. Patients who have previously failed dental implants at the site intended for study implant placement. 3. Patients with active HIV or Hepatitis infection.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Edentulous jaw are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Jaw, Edentulous

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Edentulous jaw

Contacts and locations

Locations

  • Dr. Daniel Engler-Hamm

    München, 80333, Germany

  • Jersey Shore University Medical Center

    Neptune City, New Jersey, 07753, United States

  • University of Florida

    Gainesville, Florida, 32610, United States

  • Virginia Commonwealth University

    Richmond, Virginia, 23298, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.